Position in PYXS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,296,106
+$1,780,156 QoQ
Shares Held
4,997,333
+4.2% QoQ
Ownership
7.89%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2
of 78 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laurion Capital Management LP holds $248,360,790 across 18 Biotechnology names. PYXS ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,262,651 | $93,764,463 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,232,040 | $60,465,963 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,822,638 | $33,559,117 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,922,656 | $17,207,771 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
This page
|
4,997,333 | $7,296,106 | |
| 6 | VOR |
Vor Biopharma Inc.
|
318,670 | $5,685,072 | |
| 7 | PEPG |
PepGen Inc.
|
2,750,855 | $4,869,013 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $4,576,943 |
All Filings in PYXS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,296,106 | 4,997,333 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,515,950 | 4,796,479 | Shares | Sole | 2026-02-09 | |
| 2025-12-31 | $5,515,950 | 4,796,479 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,049,662 | 3,625,974 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,988,571 | 3,625,974 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,553,454 | 3,625,974 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,656,519 | 3,625,974 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,307,324 | 3,625,974 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,780,502 | 3,861,179 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,448,622 | 3,861,179 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,707,445 | 3,170,803 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,309,897 | 3,170,803 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,117,255 | 3,170,803 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,714,920 | 3,170,803 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,248,876 | 3,170,803 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,246,481 | 3,170,803 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,546,511 | 3,170,803 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,928,121 | 1,219,832 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,750,782 | 1,162,332 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||